Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Assessment of the SFlt-1 and sFlt-1/25(OH)D Ratio as a Diagnostic Tool in Gestational Hypertension (GH), Preeclampsia (PE), and Gestational Diabetes Mellitus (GDM).

Walentowicz-Sadlecka M, Domaracki P, Sadlecki P, Siodmiak J, Grabiec M, Walentowicz P, Moliz MTA, Odrowaz-Sypniewska G.

Dis Markers. 2019 Aug 6;2019:5870239. doi: 10.1155/2019/5870239. eCollection 2019.

2.

Expression of zinc finger transcription factors (ZNF143 and ZNF281) in serous borderline ovarian tumors and low-grade ovarian cancers.

Sadłecki P, Grabiec M, Grzanka D, Jóźwicki J, Antosik P, Walentowicz-Sadłecka M.

J Ovarian Res. 2019 Mar 18;12(1):23. doi: 10.1186/s13048-019-0501-9.

3.

The analysis of human leukocyte antigen-G level in patients with endometrial cancer by Western blot technique.

Walentowicz-Sadlecka M, Dziobek K, Grabiec M, Sadlecki P, Walentowicz P, Mak P, Szymankiewicz M, Kwinta P, Dutsch-Wicherek M.

Am J Reprod Immunol. 2019 Jan;81(1):e13070. doi: 10.1111/aji.13070. Epub 2018 Nov 29.

PMID:
30414280
4.

Expression of selected epithelial-mesenchymal transition transcription factors in serous borderline ovarian tumors and type I ovarian cancers.

Sadlecki P, Jóźwicki J, Antosik P, Grabiec M.

Tumour Biol. 2018 Jun;40(6):1010428318784807. doi: 10.1177/1010428318784807.

PMID:
29952249
5.

Why do patients decline amniocentesis? Analysis of factors influencing the decision to refuse invasive prenatal testing.

Sadlecki P, Grabiec M, Walentowicz P, Walentowicz-Sadlecka M.

BMC Pregnancy Childbirth. 2018 May 16;18(1):174. doi: 10.1186/s12884-018-1812-3.

6.

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas.

Sadlecki P, Grzanka D, Grabiec M.

Dis Markers. 2018 Feb 25;2018:1497879. doi: 10.1155/2018/1497879. eCollection 2018.

7.

Human Adipose-Derived and Amniotic Fluid-Derived Stem Cells: A Preliminary In Vitro Study Comparing Myogenic Differentiation Capability.

Bajek A, Olkowska J, Walentowicz-Sadłecka M, Sadłecki P, Grabiec M, Porowińska D, Drewa T, Roszkowski K.

Med Sci Monit. 2018 Mar 24;24:1733-1741.

8.

Calcium signaling mediates five types of cell morphological changes to form neural rosettes.

Hříbková H, Grabiec M, Klemová D, Slaninová I, Sun YM.

J Cell Sci. 2018 Feb 12;131(3). pii: jcs206896. doi: 10.1242/jcs.206896.

9.

Molecular diagnosis in type I epithelial ovarian cancer.

Sadłecki P, Walentowicz-Sadłecka M, Grabiec M.

Ginekol Pol. 2017;88(12):692-697. doi: 10.5603/GP.a2017.0123. Review.

10.

Obstetric outcomes of pre-induction of labor with a 200 μg misoprostol vaginal insert.

Jagielska I, Kazdepka-Ziemińska A, Tyloch M, Sopońska-Brzoszczyk P, Nowak K, Dziedzic D, Dzikowska E, Grabiec M.

Ginekol Pol. 2017;88(11):606-612. doi: 10.5603/GP.a2017.0109.

11.

Vaspin mRNA levels in the liver of morbidly obese women with nonalcoholic fatty liver disease.

Waluga M, Kukla M, Żorniak M, Grabiec M, Kajor M, Dyaczyński M, Kowalski G, Żądło D, Berdowska A, Kotulski R, Bułdak RJ, Sawczyn T, Waluga E, Olczyk P, Hartleb M.

Pol J Pathol. 2017;68(2):128-137. doi: 10.5114/pjp.2017.69688.

12.

KRAS mutation testing in borderline ovarian tumors and low-grade ovarian carcinomas with a rapid, fully integrated molecular diagnostic system.

Sadlecki P, Antosik P, Grzanka D, Grabiec M, Walentowicz-Sadlecka M.

Tumour Biol. 2017 Oct;39(10):1010428317733984. doi: 10.1177/1010428317733984.

PMID:
28992761
13.

Determination of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in borderline and low-grade ovarian cancers.

Sadlecki P, Walentowicz P, Bodnar M, Marszalek A, Grabiec M, Walentowicz-Sadlecka M.

Tumour Biol. 2017 May;39(5):1010428317706230. doi: 10.1177/1010428317706230.

PMID:
28488545
14.

Stage-specific roles of FGF2 signaling in human neural development.

Grabiec M, Hříbková H, Vařecha M, Střítecká D, Hampl A, Dvořák P, Sun YM.

Stem Cell Res. 2016 Sep;17(2):330-341. doi: 10.1016/j.scr.2016.08.012. Epub 2016 Aug 27.

15.

Serum 25(OH) Vitamin D Levels in Polish Women during Pregnancies Complicated by Hypertensive Disorders and Gestational Diabetes.

Domaracki P, Sadlecki P, Odrowaz-Sypniewska G, Dzikowska E, Walentowicz P, Siodmiak J, Grabiec M, Walentowicz-Sadlecka M.

Int J Mol Sci. 2016 Sep 27;17(10). pii: E1574.

16.

Prenatal Clinical Assessment of NT-proBNP as a Diagnostic Tool for Preeclampsia, Gestational Hypertension and Gestational Diabetes Mellitus.

Sadlecki P, Grabiec M, Walentowicz-Sadlecka M.

PLoS One. 2016 Sep 29;11(9):e0162957. doi: 10.1371/journal.pone.0162957. eCollection 2016.

17.

High Quality Independent From a Donor: Human Amniotic Fluid Derived Stem Cells-A Practical Analysis Based on 165 Clinical Cases.

Bajek A, Olkowska J, Walentowicz-Sadłecka M, Walentowicz P, Sadłecki P, Grabiec M, Bodnar M, Marszałek A, Dębski R, Porowińska D, Czarnecka J, Kaźmierski Ł, Drewa T.

J Cell Biochem. 2017 Jan;118(1):116-126. doi: 10.1002/jcb.25618. Epub 2016 Jun 28.

PMID:
27261372
18.

[Evaluation of carbetocin and oxytocin efficacy in prevention of postpartum hemorrhage in women after cesarean section].

Jagielska I, Kazdepka-Ziemińska A, Kaczorowska A, Madej A, Kolossa T, Grabiec M.

Ginekol Pol. 2015 Sep;86(9):689-93. Polish.

PMID:
26665571
19.

Postsynaptic gephyrin clustering controls the development of adult-born granule cells in the olfactory bulb.

Deprez F, Pallotto M, Vogt F, Grabiec M, Virtanen MA, Tyagarajan SK, Panzanelli P, Fritschy JM.

J Comp Neurol. 2015 Sep 1;523(13):1998-2016. doi: 10.1002/cne.23776.

20.
21.
22.

[Clinical study of perinatal hysterectomy between 2000-2011 in the clinic of obstetrics, gynecological diseases and oncological gynecology in Bydgoszcz].

Jagielska I, Kazdepka-Ziemińska A, Tyloch M, Papierski M, Zołniezewicz K, Grabiec M, Szymański W.

Ginekol Pol. 2014 Mar;85(3):192-6. Polish.

PMID:
24783430
23.

The role of Hypoxia-inducible factor-1 α , glucose transporter-1, (GLUT-1) and carbon anhydrase IX in endometrial cancer patients.

Sadlecki P, Bodnar M, Grabiec M, Marszalek A, Walentowicz P, Sokup A, Zegarska J, Walentowicz-Sadlecka M.

Biomed Res Int. 2014;2014:616850. doi: 10.1155/2014/616850. Epub 2014 Mar 12.

24.

The preoperative maximum standardized uptake value measured by 18F-FDG PET/CT as an independent prognostic factor of overall survival in endometrial cancer patients.

Walentowicz-Sadlecka M, Malkowski B, Walentowicz P, Sadlecki P, Marszalek A, Pietrzak T, Grabiec M.

Biomed Res Int. 2014;2014:234813. doi: 10.1155/2014/234813. Epub 2014 Jan 20.

25.

Human amniotic-fluid-derived stem cells: a unique source for regenerative medicine.

Bajek A, Olkowska J, Gurtowska N, Kloskowski T, Walentowicz-Sadlecka M, Sadlecki P, Grabiec M, Drewa T.

Expert Opin Biol Ther. 2014 Jun;14(6):831-9. doi: 10.1517/14712598.2014.898749. Epub 2014 Mar 22. Review.

PMID:
24655038
26.

Serum inhibin A and inhibin B levels in epithelial ovarian cancer patients.

Walentowicz P, Krintus M, Sadlecki P, Grabiec M, Mankowska-Cyl A, Sokup A, Walentowicz-Sadlecka M.

PLoS One. 2014 Mar 5;9(3):e90575. doi: 10.1371/journal.pone.0090575. eCollection 2014.

27.

Stromal derived factor-1 (SDF-1) and its receptors CXCR4 and CXCR7 in endometrial cancer patients.

Walentowicz-Sadlecka M, Sadlecki P, Bodnar M, Marszalek A, Walentowicz P, Sokup A, Wilińska-Jankowska A, Grabiec M.

PLoS One. 2014 Jan 9;9(1):e84629. doi: 10.1371/journal.pone.0084629. eCollection 2014.

28.

Analysis of serum protein fractions from women with recurrent miscarriage.

Nowak-Łoś L, Odrowaz-Sypniewska G, Zegarska J, Zalewska-Zacharek M, Kłyszejko-Molska J, Grabiec M, Adamczak R.

Ginekol Pol. 2013 Oct;84(10):851-6.

PMID:
24273907
29.

[SUVmax measured by 18F FDG PET/CT in the primary tumor in relation to clinical and pathological features of endometrial cancer].

Walentowicz-Sadłecka M, Sadłecki P, Małecki B, Walentowicz P, Marszałek A, Domaracki P, Grabiec M.

Ginekol Pol. 2013 Sep;84(9):748-53. Polish.

PMID:
24191511
30.

Serum anti-müllerian hormone levels in patients with epithelial ovarian cancer.

Walentowicz P, Sadlecki P, Krintus M, Sypniewska G, Mankowska-Cyl A, Grabiec M, Walentowicz-Sadlecka M.

Int J Endocrinol. 2013;2013:517239. doi: 10.1155/2013/517239. Epub 2013 Jul 28.

31.

Altered expression of ERs, aromatase, and COX2 connected to estrogen action in type 1 endometrial cancer biology.

Jarzabek K, Koda M, Walentowicz-Sadlecka M, Grabiec M, Laudanski P, Wolczynski S.

Tumour Biol. 2013 Dec;34(6):4007-16. doi: 10.1007/s13277-013-0991-9. Epub 2013 Jul 20.

32.

[The role of vitamin D in the carcinogenesis of breast and ovarian cancer].

Walentowicz-Sadłecka M, Sadłecki P, Walentowicz P, Grabiec M.

Ginekol Pol. 2013 Apr;84(4):305-8. Review. Polish.

PMID:
23700865
33.

[Evaluation of the efficacy and safety of Foley catheter pre-induction of labor].

Jagielska I, Kazdepka-Ziemińska A, Janicki R, Fórmaniak J, Walentowicz-Sadłecka M, Grabiec M.

Ginekol Pol. 2013 Mar;84(3):180-5. Polish.

PMID:
23700844
34.

Expression of estrogen receptors (α, β), cyclooxygenase-2 and aromatase in normal endometrium and endometrioid cancer of uterus.

Knapp P, Chabowski A, Błachnio-Zabielska A, Walentowicz-Sadłecka M, Grabiec M, Knapp PA.

Adv Med Sci. 2013;58(1):96-103. doi: 10.2478/v10039-012-0055-1.

PMID:
23625281
35.

The analysis of metallothionein immunoreactivity in stromal fibroblasts and macrophages in cases of uterine cervical carcinoma with respect to both the local and distant spread of the disease.

Walentowicz-Sadlecka M, Koper A, Krystyna G, Koper K, Basta P, Mach P, Skret-Magierlo J, Dutsch-Wicherek M, Sikora J, Grabiec M, Kazmierczak W, Wicherek L.

Am J Reprod Immunol. 2013 Sep;70(3):253-61. doi: 10.1111/aji.12120. Epub 2013 Apr 17.

PMID:
23590599
36.

[The phenomenon of alcoholism in Poland as a legal issue].

Jagielska-Burduk A, Jagielska I, Janicki R, Grabiec M.

Przegl Lek. 2012;69(10):1115-7. Review. Polish.

PMID:
23421103
37.

[Cigarette smoking among women attending cervical cancer screening program].

Walentowicz-Sadłecka M, Sadłecki P, Marszałek A, Grabiec M.

Przegl Lek. 2012;69(10):914-7. Polish.

PMID:
23421059
38.

25(OH)D3 in patients with ovarian cancer and its correlation with survival.

Walentowicz-Sadlecka M, Grabiec M, Sadlecki P, Gotowska M, Walentowicz P, Krintus M, Mankowska-Cyl A, Sypniewska G.

Clin Biochem. 2012 Dec;45(18):1568-72. doi: 10.1016/j.clinbiochem.2012.07.110. Epub 2012 Aug 4.

PMID:
22884489
39.

Response to novelty in the laboratory Wistar rat, wild-captive WWCPS rat, and the gray short-tailed opossum (Monodelphis domestica).

Pisula W, Turlejski K, Stryjek R, Nałęcz-Tolak A, Grabiec M, Djavadian RL.

Behav Processes. 2012 Oct;91(2):145-51. doi: 10.1016/j.beproc.2012.06.010. Epub 2012 Jul 7.

PMID:
22776746
40.

The expression of suppressor of cytokine signaling 1 and 3 in fat and placental tissue from women with gestational diabetes.

Kuzmicki M, Telejko B, Wawrusiewicz-Kurylonek N, Citko A, Lipinska D, Pliszka J, Wilk J, Kalejta K, Lemancewicz A, Grabiec M, Pryszczepko-Wawreszuk AM, Skibicka J, Kretowski A, Gorska M, Szamatowicz J.

Gynecol Endocrinol. 2012 Nov;28(11):841-4. doi: 10.3109/09513590.2012.683055. Epub 2012 May 16.

PMID:
22587677
41.

Elevation of sE-Selectin Levels 2-24 Months following Gestational Diabetes Is Associated with Early Cardiometabolic Risk in Nondiabetic Women.

Sokup A, Ruszkowska B, Góralczyk B, Góralczyk K, Szymański M, Grabiec M, Rość D.

Int J Endocrinol. 2012;2012:278050. doi: 10.1155/2012/278050. Epub 2012 Apr 22.

43.

Analysis of RCAS1 immunoreactivity within hydatidiform mole cells and decidual cells according to the applied therapeutic strategy: surgery or surgery followed by chemotherapy.

Wicherek L, Basta P, Wertel I, Kojs Z, Malkowski B, Grabiec M, Pietrus M, Krystyna G.

Gynecol Obstet Invest. 2012;73(2):106-12. doi: 10.1159/000328509. Epub 2012 Jan 24.

PMID:
22269478
44.

[Comparison of VEGF, IL-8 and beta-FGF concentrations in the serum and ascites of patients with ovarian cancer].

Sadłecki P, Walentowicz-Sadłecka M, Szymański W, Grabiec M.

Ginekol Pol. 2011 Jul;82(7):498-502. Polish.

PMID:
21913426
45.

The expression of transcription factor 7-like 2 (TCF7L2) in fat and placental tissue from women with gestational diabetes.

Kuzmicki M, Telejko B, Wawrusiewicz-Kurylonek N, Kalejta K, Lemancewicz A, Zdrodowski M, Grabiec M, Pryszczepko-Wawreszuk AM, Kretowski A, Gorska M, Szamatowicz J.

Diabetes Res Clin Pract. 2011 Nov;94(2):e43-6. doi: 10.1016/j.diabres.2011.07.033. Epub 2011 Aug 19.

PMID:
21855162
46.

New model describing adsorption from liquid binary mixtures of nonelectrolytes with limited and unlimited miscibility of components.

Garbacz JK, Furmaniak S, Terzyk AP, Grabiec M.

J Colloid Interface Sci. 2011 Jul 15;359(2):512-9. doi: 10.1016/j.jcis.2011.04.019. Epub 2011 Apr 16.

PMID:
21543079
47.

Prenatally evolving ectopia cordis with successful surgical treatment.

Sadłecki P, Krekora M, Krasomski G, Walentowicz-Sadłecka M, Grabiec M, Moll J, Respondek-Liberska M.

Fetal Diagn Ther. 2011;30(1):70-2. doi: 10.1159/000326300. Epub 2011 Apr 21.

48.

Adult neurogenesis in the hedgehog (Erinaceus concolor) and mole (Talpa europaea).

Bartkowska K, Turlejski K, Grabiec M, Ghazaryan A, Yavruoyan E, Djavadian RL.

Brain Behav Evol. 2010;76(2):128-43. doi: 10.1159/000320944. Epub 2010 Nov 15.

PMID:
21079393
49.

The frequency of CD25+CD4+ and FOXP3+ regulatory T cells in ectopic endometrium and ectopic decidua.

Basta P, Majka M, Jozwicki W, Lukaszewska E, Knafel A, Grabiec M, Stasienko E, Wicherek L.

Reprod Biol Endocrinol. 2010 Oct 5;8:116. doi: 10.1186/1477-7827-8-116.

50.

[Predictive value of CA 125 in detection of ovarian cancer in pre- and postmenopausal patients].

Grzybowski W, Beta J, Fritz A, Durczyński A, Bidziński M, Grabiec M, Jakimiuk AJ.

Ginekol Pol. 2010 Jul;81(7):511-5. Polish.

PMID:
20825052

Supplemental Content

Loading ...
Support Center